Lohmann C H, Andreacchio D, Köster G, Carnes D L, Cochran D L, Dean D D, Boyan B D, Schwartz Z
Department of Orthopaedics, Georg-August Universität, Göttingen, Germany.
Arch Orthop Trauma Surg. 2001 Nov;121(10):583-90. doi: 10.1007/s004020100291.
Freeze-dried human bone allograft is used clinically as an adjunct to autologous bone graft. When freeze-dried human bone allograft is demineralized, the allograft is osteoinductive, since it causes bone to form heterotopically. Both types of allograft are also used alone, such as in spinal fusions, critical size defects, and periodontal therapy. The purpose of this study was to determine the effect of demineralization on the osteoinductive potential of human bone grafts obtained from two different groups of patients. One group consisted of six patients younger than 42 years of age, while the other group consisted of six patients who were older than 70 years of age. The harvested material was lyophilized and divided into two portions, one of which was used directly while the other was demineralized. Osteoinductive ability was established using an in vivo assay for heterotopic bone formation. Activity in these bone grafts was compared with a batch of commercially prepared demineralized, freeze-dried human bone grafts that had been previously shown to be active and another batch that had been shown to display low ('inactive') osteoinductive ability. A bone induction score was determined for each group of grafts based on the number and size of any ossicles formed. In addition, the area of new bone formation and area of residual particles were determined histomorphometrically. Tissue response to the bone grafts varied with donor age and whether the samples had been demineralized or not. Only demineralized, freeze-dried bone graft from patients younger than 42 years of age was osteoinductive; all other batches displayed little or no osteoinductive activity. In the demineralized, freeze-dried bone from donors younger than 42 years of age, the bone induction score and new bone area were significantly higher than in the other batches of bone graft, and the area of residual particles was reduced. Both demineralized and nondemineralized bone graft from patients older than 70 years of age were encapsulated in dense, fibrous connective tissue. These results may help explain the observed differences in clinical outcome when demineralized, freeze-dried bone graft or nondemineralized, freeze-dried bone graft from different donors is used in bone regeneration applications.
冻干人同种异体骨在临床上用作自体骨移植的辅助材料。当冻干人同种异体骨脱矿后,该同种异体骨具有骨诱导性,因为它能在异位诱导骨形成。这两种类型的同种异体骨也可单独使用,如用于脊柱融合、临界尺寸骨缺损和牙周治疗。本研究的目的是确定脱矿对从两组不同患者获取的人骨移植骨骨诱导潜能的影响。一组由6名年龄小于42岁的患者组成,而另一组由6名年龄大于70岁的患者组成。采集的材料经冻干后分成两部分,一部分直接使用,另一部分进行脱矿处理。利用异位骨形成的体内试验确定骨诱导能力。将这些骨移植骨的活性与一批先前已证明具有活性的市售脱矿冻干人骨移植骨以及另一批已证明具有低(“无活性”)骨诱导能力的骨移植骨进行比较。根据形成的任何小骨的数量和大小为每组移植骨确定骨诱导评分。此外,通过组织形态计量学确定新骨形成面积和残留颗粒面积。组织对骨移植骨的反应因供体年龄以及样本是否脱矿而有所不同。只有来自年龄小于42岁患者的脱矿冻干骨具有骨诱导性;所有其他批次的骨移植骨几乎没有或没有骨诱导活性。在来自年龄小于42岁供体的脱矿冻干骨中,骨诱导评分和新骨面积显著高于其他批次的骨移植骨,且残留颗粒面积减小。来自年龄大于70岁患者的脱矿和未脱矿骨移植骨均被致密的纤维结缔组织包裹。这些结果可能有助于解释在骨再生应用中使用来自不同供体的脱矿冻干骨移植骨或未脱矿冻干骨移植骨时观察到的临床结果差异。